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Background: Myocardial T1 and T2 mapping using cardiovascular magnetic resonance (CMR) are promising to
improve tissue characterization and early disease detection. This study aimed at analyzing the feasibility of T1 and T2
mapping at 3 T and providing reference values.
Methods: Sixty healthy volunteers (30 males/females, each 20 from 20–39 years, 40–59 years, 60–80 years)
underwent left-ventricular T1 and T2 mapping in 3 short-axis slices at 3 T. For T2 mapping, 3 single-shot steady-state
free precession (SSFP) images with different T2 preparation times were acquired. For T1 mapping, modified
Look-Locker inversion recovery technique with 11 single shot SSFP images was used before and after injection of
gadolinium contrast. T1 and T2 relaxation times were quantified for each slice and each myocardial segment.
Results: Mean T2 and T1 (pre-/post-contrast) times were: 44.1 ms/1157.1 ms/427.3 ms (base), 45.1 ms/1158.7 ms/411.2 ms
(middle), 46.9 ms/1180.6 ms/399.7 ms (apex). T2 and pre-contrast T1 increased from base to apex, post-contrast
T1 decreased. Relevant inter-subject variability was apparent (scatter factor 1.08/1.05/1.11 for T2/pre-contrast
T1/post-contrast T1). T2 and post-contrast T1 were influenced by heart rate (p < 0.0001, p = 0.0020), pre-contrast
T1 by age (p < 0.0001). Inter- and intra-observer agreement of T2 (r = 0.95; r = 0.95) and T1 (r = 0.91; r = 0.93)
were high. T2 maps: 97.7% of all segments were diagnostic and 2.3% were excluded (susceptibility artifact).
T1 maps (pre-/post-contrast): 91.6%/93.9% were diagnostic, 8.4%/6.1% were excluded (predominantly
susceptibility artifact 7.7%/3.2%).
Conclusions: Myocardial T2 and T1 reference values for the specific CMR setting are provided. The diagnostic
impact of the high inter-subject variability of T2 and T1 relaxation times requires further investigation.
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Cardiovascular magnetic resonance (CMR) provides tech-
niques for non-invasive myocardial tissue characterization.
T1 and T2 mapping of the left ventricular myocardium,
i.e. quantification of the myocardial T1 and T2 relaxation
times, as well as the T1-derived extracellular volume
fraction have been demonstrated to add valuable informa-
tion [1-6]. Most of the experience with myocardial* Correspondence: florian.von-knobelsdorff@charite.de
1Berlin Ultrahigh Field Facility, Max-Delbrueck Center for Molecular Medicine,
Berlin, Germany
2Working Group on Cardiovascular Magnetic Resonance, Experimental and
Clinical Research Center a joint cooperation between the Charité Medical
Faculty and the Max-Delbrueck Center for Molecular Medicine HELIOS
Klinikum Berlin Buch, Department of Cardiology and Nephrology,
Lindenberger Weg 80, 13125, Berlin, Germany
Full list of author information is available at the end of the article
© 2013 von Knobelsorff-Brenkenhoff et al.; lice
terms of the Creative Commons Attribution L
use, distribution, and reproduction in any medmapping was gained at a magnetic field strength of 1.5 T.
Parametric myocardial mapping at 3 T is conceptually
appealing due to the signal gain inherent to higher
fields, which may be exploited for improved spatial
and temporal resolution [7]. Many of the previous
studies focused on intra-individual comparison of
diseased and remote myocardium. However, T2 and T1
reference values of all myocardial segments may be
important to define small focal abnormalities and to
identify diffuse tissue changes in the absence of
healthy “remote” myocardium. For all these reasons
this study scrutinizes myocardial T1 and T2 at 3 T in
a large sample of healthy volunteers using state-of-the
art mapping techniques.nsee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited.
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Study population
60 healthy volunteers were enrolled into the study (30
men/30 women, equally distributed within 3 age cat-
egories (Table 1)). The status “healthy” was based on: i)
uneventful medical history, ii) absence of any symptoms
indicating cardiovascular dysfunction, iii) normal ECG,
iv) normal cardiac dimensions and function proven by
cine CMR. v) normal myocardial tissue assessed by late
enhancement (LGE). For each volunteer written in-
formed consent was obtained prior to the study, after
due approval by the ethical committee of the Charité
Medical Faculty (EA2/077/10). All experiments were
performed in compliance with the Helsinki Declaration.
CMR examination
All CMR exams were performed with a 3 T system
(Magnetom Verio, Siemens Healthcare, Erlangen, Germany)
using a 32-channel cardiac RF coil for signal reception, the
integrated body RF coil for transmission, and ECG for car-
diac gating. Subject-specific, volume-selective first- and
second-order B0-shimming based on field maps derived
from double-gradient-echo acquisitions was performed
to improve static field uniformity. The following CMR
protocols were used (Figure 1).
Cine imaging
Steady-state free-precession (SSFP) cine images were
obtained during repeated breath-holds in three long axes
(horizontal, vertical, and 3-chamber) and in a stack ofTable 1 Characteristics of the volunteers
Parameter Result
Number 60
Females/Males 30/30
Age [years] 48 ± 17
Age group 20–39 years 20 (10 Males/10 Females)
Age group 40–59 years 20 (10 Males/10 Females)
Age group 60–80 years 20 (10 Males/10 Females)
Height [cm] 173 ± 9
Weight [kg] 76 ± 14
Body mass index [kg/m2] 25 ± 4
Body surface area [m2] 1.9 ± 0.2
Systolic blood pressure [mm/Hg] 132 ± 12
Diastolic blood pressure [mm/Hg] 72 ± 11
Heart rate [min-1] 70 ± 6
LV enddiastolic volume [ml] 143 ± 35
LV enddiastolic volume index [ml/cm] 0.8 ± 0.2
LV ejection fraction [%] 64 ± 5
LV mass [mg] 101 ± 26
LV mass index [mg/cm] 0.6 ±0.2short axes (SAX) covering the left ventricle (LV) to as-
sess wall motion and for cardiac chamber quantification.
Imaging parameters were: repetition time (TR) 3.1 ms,
echo time (TE) 1.3 ms, asymmetric echo with factor
0.29, flip angle (FA) 45°, field of view (FOV) (276 × 340)
mm2, matrix 156 × 192, slice thickness 6 mm, receiver
bandwidth (BW) 704Hz/px, parallel imaging using
GRAPPA reconstruction (R = 2), 30 cardiac phases.T2 mapping
For T2 mapping, data were acquired in basal, mid-
ventricular, and apical SAX planes using a T2-prepared
single-shot SSFP technique similar to the one described
for 1.5 T [2]. For the application on a 3 T platform, the
RF pulse length of the SSFP readout module was
increased to reduce the SAR deposition and adiabatic T2
preparation pulses were employed to improve the homo-
geneity of the T2 weighting. Three SSFP images, each
with different T2 preparation time (TET2P = 0 ms, 24 ms,
55 ms) were acquired in end-diastole within one breath-
hold. Imaging parameters were: TR = 2.4 ms, TE =
1 ms, FA = 70°, FOV = (340 × 278) mm2, matrix = 176 ×
144, slice thickness = 6 mm, BW= 1093Hz/px, GRAPPA
acceleration factor 2, linear phase encoding scheme. To
correct for residual cardiac and respiratory motion be-
tween image sets, a non-rigid registration algorithm was
used [8]. A pixel-wise myocardial T2-map was generated
using unsupervised curve-fitting based on a two-
parameter equation [2]. The single shot SSFP readout
and use of only three TET2P was chosen to balance
accuracy and acquisition time (7 heart cycles) [2,9].T1 mapping
For T1 mapping, data were acquired in basal, mid-
ventricular, and apical SAX planes before and 10 -
minutes after administration of 0.2 mmol/kg i.v.
gadobutrol (Gadovist®, Bayer Healthcare Germany).
Data were obtained in end-diastole using a cardiac-
gated, SSFP-based Modified Look-Locker Inversion
Recovery (MOLLI) technique [10]. For the application
at 3 T, the RF pulse length of the SSFP readout module
was increased to reduce the SAR deposition. Imaging pa-
rameters were: TR = 2.6-2.7 ms, TE = 1.0-1.1 ms, FA = 35°,
FOV= (270 × 360)mm2, matrix = 156 × 208 to 168 × 224,
slice thickness = 6 mm, BW= 1045-1028Hz/px, GRAPPA
acceleration factor 2, linear phase-encoding ordering,
minimum TI of 91 ms. To generate a pixel-wise myocar-
dial T1-map, single-shot SSFP images were acquired at dif-
ferent inversion times (pattern 3-3-5, [10]) and registered
[8] prior to a non-linear least-square curve fitting using
S(TI) = A - B exp(−TI/T1*) with T1 = T1 × (B/A - 1),
where A, B, and T1* are estimated by a three parameter fit
[11]. In-plane voxel dimensions were kept isotropic to
Figure 1 CMR protocol. This schematic diagram illustrates the chronological sequence of the applied CMR techniques.
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rotation.LGE imaging
LGE imaging was performed in the same planes as SSFP
CINE imaging using a segmented inversion-recovery
gradient-echo sequence beginning 15 minutes after con-
trast administration. The inversion time (TI) was repeat-
edly adjusted to appropriately null the myocardium
during the length of LGE image acquisition. Imaging
parameters were: TR = 10.5 ms, TE = 5.4 ms, FA = 30°,
FOV (350 × 262) mm2, matrix 256 × 162, slice thickness
6 mm, BW 140Hz/px, GRAPPA acceleration factor 2.CMR image analysis
Image analysis was done using CMR42 (Circle Cardiovas-
cular Imaging, Calgary, Canada).LV chamber quantification
SSFP cine images were visually evaluated regarding wall
motion abnormalities. LV enddiastolic and endsystolic
volume and LV mass were determined by manually
contouring the endocardial and epicardial borders of the
SAX in systole and diastole.LGE assessment
The absence of LGE was determined qualitatively by
visual assessment.T2 and T1 mapping - qualitative assessment
Each single original image was assessed regarding arti-
facts caused by susceptibility effects, cardiac or respira-
tory motion. Each motion-corrected series was evaluated
whether the images were correctly aligned. Each map
was evaluated whether the original images were trans-
formed to a reasonably appearing map. The presence of
artifacts led to the exclusion of all affected myocardial
segments. Two experienced readers assessed quality
in consensus.T2 mapping - quantitative assessment
The LV myocardium was delineated by manually con-
touring the endocardial and epicardial border. We
ensured that the region of interest (ROI) was definitely
within the myocardium and did not include blood or
epicardial fat based. An endocardial and epicardial
contour was drawn in one original motion-corrected
image. The trabeculated layer and the epicardial border
were left out. In doubt, SSFP cine images were
consulted. The contours were copied to the other images
and adapted to fit in all of these. These final contours
were copied to the map. The myocardial ROI was auto-
matically segmented according to the AHA segment
model [12]. Results are presented both per segment and
averaged per slice.
T1 mapping - quantitative assessment
T1 values were recorded from pre-contrast and post-
contrast T1 maps applying the same procedure as for T2.
T2 and T1 mapping - Observer dependency
Intra- and interobserver variability were tested in a
subgroup of 20 randomly selected subjects (320 myocar-
dial segments), where one observer measured T2 and
pre-contrast T1 values of each LV segment twice with at
least 3 months of time between the measurements. A
second observer measured T2 and pre-contrast T1 values
blinded to the other results.
Statistical analysis
Baseline characteristics are shown as means with stand-
ard deviation (SD) or absolute frequencies. Relaxation
times are displayed as least-square means with 95%
tolerance intervals (90% coverage) and were assessed by
slice and by segment using mixed linear models on loga-
rithmic transformed data to ensure normal distributed
data. The following co-factors were included into each
model to assess their impact on the relaxation times: age
(categories), gender, heart rate (binary with split at
median), blood pressure and excluded backwards if not
significant. For T1 and T2, the scatter factor was
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interpretation as the coefficient of variation for non-
transformed data. All values presented were back
transformed using the exponential to present the data
on the original scale. Spearman's correlation coefficients
were calculated to evaluate correlations between the
co-factors, which may interfere with the modelling. A
p-value of less than 0.05 was regarded as statistically
significant. Calculations were performed using SAS 9.2
(SAS Institute Inc., Cary, NC, USA). Intra- and inter-
observer dependency was assessed by Bland-Altman
analysis and Pearson’s correlation using Prism 5.0
(Graphpad Software, La Jolla, CA, USA).
Results
CMR
All 60 CMR scans were performed without major
adverse events. The scans were incomplete in 4 subjects.
T2 maps were available for 58 subjects, pre-contrast T1
maps for 59 subjects and post-contrast T1 maps for 57
subjects.
T2 mapping
From 922 segments, 901 (97.7%) were eligible for ana-
lysis (Figure 2). A full set of original data and corre-
sponding maps is available as additional file (see
Additional file 1). Twenty-one segments (2.3%) wereFigure 2 Quality assessment of T2 and T1 maps. The bar graphs
show the prevalence of images approved as evaluable, as well as
the frequency of susceptibility artifacts, incorrect motion correction,
and mistriggering for each technique.excluded due to a susceptibility artifact (Figures 2 and 3)
mainly in the inferior/inferolateral wall (18 out of 21;
85.7%). Exclusion of at least one segment affected 12 out
of 58 subjects (20.7%).
T2 relaxation times per slice are shown in Table 2.
Mean value was 44.1 ms (base), 45.1 ms (middle) and
46.9 ms (apex). All slices differed significantly (p < 0.0001)
with increasing values from base to apex.
T2 values for each myocardial segment are presented
in Figure 4. Significant segment-to-segment differences
were observed in the basal slice (p = 0.0036) with slightly
lower values in the anterior wall compared to inferior.
No significant segment-to-segment differences were
found for the midventricular (p = 0.5398) and apical
slices (p = 0.1367). The distribution of all individual T2
results is illustrated in Figure 5. A relevant inter-subject
variability was evident as indicated by a scatter factor of
1.08 (Figure 5 and Table 2).
Heart rate (ranging from 47 to 102 min-1) was found
to significantly influence T2 measurements (p < 0.0001).
A heart rate higher than the median (69.5 min-1) was
associated with lower T2 values (base: 42.8 ms vs.
45.8 ms; middle: 43.9 ms vs. 46.5 ms; apex: 45.7 ms vs.
48.2 ms). Other tested cofactors including age and
gender were not found to be significant.
Pre-contrast T1 mapping
For pre-contrast T1 mapping 938 segments were ob-
tained. 859 (91.6%) were eligible for analysis (Figure 2).
A full set of original data and corresponding maps is
available as additional file (see Additional file 2).
Seventy-two segments (7.7%) were excluded due to a
susceptibility artifact and 7 segments (0.7%) due to in-
correct motion correction (Figures 2, 6 and 7). In 63 out
of 72 segments (87.5%) with susceptibility artifact, the
inferior/inferolateral segments were affected. Exclusion
of at least one segment affected 34 out of 59 subjects
(57.6%).
T1 relaxation times per slice are shown in Table 2.
Mean value was 1157.1 ms (base), 1158.7 ms (middle)
and 1180.6 ms (apex). Apical T1 relaxation times were
significantly larger than basal and midventricular (each
p < 0.0001).
T1 values for each myocardial segment are shown in
Figure 4. A significant segment-to-segment difference was
found for each slice (basal: p < 0.0001; mid: p < 0.0001;
apex: p = 0.0153). T1 of the anterior segment was lower
than in the other segments. The distribution of all individ-
ual T1 results is illustrated in Figure 5. A relevant inter-
subject variability was found with a scatter factor of 1.05
(Figure 5, Table 2).
The age categories were found to significantly influ-
ence myocardial T1 relaxation times (p < 0.0001). The
difference was small between age category 20–39 years
Figure 3 T2 mapping artifact. Susceptibility artifact in the inferolateral wall of the midventricular plane (red arrow; the 3 grayscale images represent
the T2-prepared SSFP images with different T2 preparation times). In the map (right image), the artifact is visible in the same area (black arrow).
von Knobelsdorff-Brenkenhoff et al. Journal of Cardiovascular Magnetic Resonance 2013, 15:53 Page 5 of 11
http://jcmr-online.com/content/15/1/53and 40–59 years. A clear decrease of T1 relaxation times
was observed for subjects ≥ 60 years (Figure 8). Other
tested cofactors including heart rate and gender were
not found to be significant.Post-contrast T1 mapping
For post-contrast T1 mapping 841 out of 896 segments
(93.9%) were eligible for analysis (Figure 2). Twenty-nine
segments (3.2%) were excluded due to a susceptibility
artifact, which mainly affected the inferior/inferolateral
segments (25 out of 29; 86.2%). Six segments (0.7%)
were excluded due to mistriggering (all in one subject).
Motion correction failed in one subject in all planes and
in one subject in the apical plane leading to an exclusion
of 20 segments (2.2%). Exclusion of at least one segment
affected 18 out of 56 subjects (32.1%).
T1 relaxation times per slice are shown in Table 2.
Mean values of 427.3 ms (base), 411.2 ms (middle) and
399.7 ms (apex) were obtained. All slices differed signifi-
cantly from each other (base vs. middle: p < 0.0001; base
vs. apex p < 0.0001; middle vs. apex: p = 0.0013) with
decreasing T1 values from base to apex.
T1 values for each myocardial segment are shown in
Figure 4. No significant segment-to-segment differ-
ences were observed for each slice (basal: p = 0.4918;
mid: p = 0.4741; apex: p = 0.5629). The distribution
of all individual T1 results is illustrated in Figure 5.
Post-contrast T1-maps revealed a relevant inter-Table 2 Myocardial T2 and T1 relaxation times [in ms] for eac
Position Least square me
T2 [ms] Base 44.1
Middle 45.1
Apex 46.9
T1 pre-contrast [ms] Base 1157.1
Middle 1158.7
Apex 1180.6
T1 post-contrast [ms] Base 427.3
Middle 411.2
Apex 399.7subject variability reflected by a scatter factor of 1.11
(Figure 5, Table 2).
Heart rate was found to significantly influence the
post-contrast T1 relaxation time (p = 0.0020) with higher
heart rates than the median (69.5 bpm) being associated
with lower post-contrast T1 relaxation times (base:
445.7 ms vs. 418.7 ms; middle: 430.1 ms vs. 405.3 ms;
apex: 427.6 ms vs. 388.0 ms). Other tested cofactors
including age and gender were not found to be
significant.
For T2 and pre-contrast T1 mapping inter- and intra-
observer analysis demonstrated close agreement (Table 3).Discussion
This study examined myocardial T1 and T2 mapping
techniques at 3 T in a large sample of healthy volun-
teers. The main findings are: i) T2 and T1 mapping
achieve a high grade of diagnostic image quality,
although susceptibility artifacts entailed the exclusion of
a limited number of myocardial segments from the ana-
lysis. ii) Observer dependency of T2 and T1 relaxation
time quantification was low. iii) Mean values and 95%
tolerance interval of myocardial T2 and T1 relaxation
times are presented per slice and per segment and can
be used as reference values specific for this MR setting.
iii) An inter-subject distribution of T2 and T1 values
became apparent and may constitute a limitation to
define appropriate cut-offs.h plane (base, middle, apex)
an 95% Tolerance interval Min-Max
39.3 – 49.5 36.2 – 53.3
39.9 – 50.1 37.9 – 57.0
40.8 – 53.8 39.1 – 59.1
1074.5 – 1246.0 965.6 – 1340.8
1074.0 – 1250.1 1005.3 – 1295.9
1073.9 – 1297.9 1106.3 – 1393.9
363.2 – 502.7 284.5 – 520.1
349.9 – 483.2 282.5 – 513.2
323.0 – 494.6 260.6 – 519.5
Figure 4 Mean T2 and T1 relaxation times. T2 and T1 relaxation times (ms) for each myocardial segment illustrated as a bulls eye plot that
represents the 16 segments of the basal (outer ring), midventricular (middle ring) and apical (central ring) short-axis plane [12]. Results are given
as least-square mean and 95% tolerance interval.
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Previous studies with SSFP-based T2 mapping at 1.5T
did not report the exclusion of segments from analysis
due to SSFP off-resonance or banding artifacts [2-4].
Hence, this challenge seems to surface at higher field
strengths due to the increase in the peak-to-peak B0
inhomogeneity across the heart. The use of an appropri-
ately selected delta frequency may be an option to
resolve some artifacts and deserves further systematic
investigation. The artifacts mainly affected the infe-
rolateral region, where pathologies like myocarditis may
also exhibit their predominant lesion [13]. Despite that,
the step from 1.5 T to 3 T for CMR is generally desired
due to expected gains in signal, which may be exploited
for improved spatial and temporal resolution. This
potential promises to enable more detailed insights into
cardiac tissue in order to facilitate the early detection of
myocardial disease.
T2 relaxation times derived from T2-prepared SSFP
imaging in this study are higher compared to a black-
blood multi-echo spin-echo approach at 3 T, which
provided a mean value of T2 = 39.6m sin the septum
[14]. Myocardial T2 reported here was found to be lower
versus a mean T2 = 52.2 ms reported for T2 prepared
SSFP imaging at 1.5 T [2]. Possible explanations are: i)
differences in the pulse sequence design, ii) differences
in the spatial resolution, with lower resolution being
associated with more partial volume and potentially
higher T2 values, and iii) T1 relaxation effects due to
higher T1 values at 3 T versus 1.5 T. Generally, myocar-
dial T2 reported in the literature varies substantially,
ranging from about 50 ms to 58 ms at 1.5 T [2]. The
heterogeneity of data underlines that the measured T2
relaxation time is very sensitive to cofactors andemphasizes the need to generate reference values spe-
cific for each technique and imaging setting.
Our results showed that T2 increased from base to
apex, which is in accordance with a recent work using a
similar mapping technique at 1.5 T [15]. The most prob-
able cause is partial-volume effects that increase towards
the apex owing to the curvature of the left ventricle. To
encounter this limitation, some groups exclude the
apical slice from mapping to omit measurement errors
[6]. We tried to minimize this error by carefully drawing
the contours in the middle of the myocardium while
leaving out the endocardial portion of the myocardium,
as well as by using an isotropic spatial resolution as high
as possible.
Most of the previous studies reported T2 values aver-
aged over all myocardial segments or only for a
midventricular slice. By averaging T2 values over the
whole slice or the whole heart, focal T2 deviations may
be overlooked. The present study is the largest study,
which reports T2 values for each myocardial segment
and slice.
As reported for the global T2 values, the segmental T2
values increased from base to apex. In comparison,
Markl et al. reported T2 values from 50.5 ms to 51.6 ms
in the basal slice and 54.3 ms to 56.1 ms in the apical
slice at 1.5 T [15].
The inter-subject variability of absolute T2 values was
relatively large both per-slice and per-segment. This
finding is in concordance with Thavendiranathan et al.,
who described T2 values ranging from about 50 ms to
62 ms in healthy controls [4], and with Giri et al., who
reported that the apical region showed the most pro-
nounced inter-subject variability [2]. The high inter-
subject variability can be considered as the main challenge
Figure 5 Individual T2 and T1 relaxation times. Distribution of all single individual T2 and T1 relaxation times in each myocardial segment. The
red lines indicate the least-square mean and the 95% confidence interval.
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healthy and injured myocardium has been reported to be
relatively small, e.g. 13 ms/11 ms between infarct core/
myocarditis and remote myocardium [3,4].
The association of heart rate and T2 relaxation time is
under discussion. Giri et al. reported that the variability
between healthy subjects was unrelated to heart rate. Other
studies reported lower T2 values in patients with higher
heart rate [1,4]. This may be attributed to the hypothesis
that higher heart rates induce pronounced T1 relaxation ef-
fects caused by incomplete T1 relaxation, which may affect
T2 mapping using a SSFP-based approach. This finding is
very relevant for clinical practice as subtle T2 increases may
disappear in acutely ill patients with higher heart rates.
T1 mapping
T1 mapping demonstrated diagnostic image quality for
the vast majority of myocardial segments. However, arelevant number of myocardial segments had to be
excluded due to technical challenges, which would lead
to diagnostic uncertainty in a clinical scenario. Previous
studies at 1.5 T and 3 T reported lower rates of artifact-
related non-diagnostic segments [7,10,16,17]. The expli-
cit source of the artifacts has not been reported in detail
in most studies, which renders benchmarking against
previous results challenging. A possible contributing
factor might be that artifacts are often only visible in the
original images - which are used for quality assessment -
while they might be not apparent in the final maps. In
our study, susceptibility artifacts in the inferolateral
region were most frequent.
The pre-contrast T1 values are in concordance with
Piechnik et al., who reported T1 = 1169 ms averaged over
all myocardial segments [16]. At 3.0 T higher mid-
ventricular T1 values (T1 = 1315 ms or T1 = 1286 ms)
were reported when using a T1 mapping technique
Figure 6 T1 mapping artifact. Susceptibility artifact in the inferolateral wall of the midventricular plane (red arrow). The artifact was located at
the border of the inferolateral and the inferior segment. In the corresponding map the artifact is hardly recognizable by visual assessment
(white arrow).
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ancies underline that T1 relaxation times are sensitive to
many influencing factors.
The myocardial T1 relaxation times reported here can
be regarded as reference values specific only for this
cohort, time point, mapping technique, type and dosage
of contrast media. Further comparisons with other pub-
lished results are difficult unless an identical study
design is used. To provide a context, Lee et al. used
0.15 mmol Gadolinium DTPA and measured a mean T1
of about 550 ms in one midventricular slice after
8.5 min in healthy human subjects at 3 T [17].
We observed that the pre-contrast T1 times increased
from base to apex, whereas the post-contrast T1 valuesFigure 7 Failed motion correction during T1 mapping. The original ima
five out of eleven images of the complete T1 acquisition are depicted). The
and anteroseptal myocardial segment (red arrow in the bottom row). The c
distribution in this area (white arrow).decreased from base to apex. Partial-volume effects
owing to the curvature of the left ventricle can most
probably explain this finding with blood signal being
included into the voxel. While some completely exclude
apical T1 maps from analysis [6], we tried to minimize
this error by excluding the endocardial portion of the
myocardium and by choosing a high isotropic spatial
resolution.
In agreement with Kawel et al. we did not observe
significant segment-to-segment differences post-contrast
[7]. However, pre-contrast T1 values of the anterior
segments were lower than T1 observed for the other seg-
ments. Interestingly, Piechnik et al. observed the identi-
cal pattern with MOLLI at 3 T [16]. Kawel et al.ges (upper row) show the regular shape of the LV myocardium (the first
motion correction algorithm led to an outbound shift of the anterior
orresponding map (right image) indicates an inhomogeneous T1
Figure 8 Age-dependency of T1 times. Myocardial pre-contrast T1 relaxation times grouped by age categories for each slice. Results are given
as mean and 95% tolerance interval.
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contrast T1 values inspite of using a different classifica-
tion into “septal” and “non-septal” myocardium [7].
Although absolute regional difference was small, this
finding has to be considered in clinical CMR interpret-
ation as the difference between healthy and abnormal
tissue might be in a similar range.
The inter-subject variability of absolute T1 values was
notable both per-slice and per-segment, including
extreme outliers. This finding is in concordance with
other T1 mapping studies reporting pre-contrast T1
values at 1.5 T ranging from 862 ms to 1105 ms in
healthy volunteers [19] and a coefficient of variation of
4.5% (pre-contrast) and 7.0% (post-contrast) [18]. The
high inter-subject range may be the main challenge of
T1 mapping, given that the difference in T1 times
between healthy and injured myocardium has been
reported to be relatively small depending on the under-
lying disease. Dall’Armellina et al. reported a mean pre-
contrast T1 value of 1257 ± 97 ms for acutely infarcted
segments compared to 1196 ± 56 ms for normal un-
affected segments at 3 T [20]. In other myocardial
diseases like Fabry’s disease or amyloidosis, pre-contrastTable 3 Intra- and inter-observer dependency of the
segmental quantification of T2 and pre-contrast T1
relaxation times
Technique Correlation
coefficient r
Bland-Altman: Bias ± SD
[ms]
T2 – Intra-
observer
0.95 0.0 ± 1.3
T2 – Inter-
observer
0.95 0.1 ± 1.1
T1 – Intra-
observer
0.93 4.6 ± 18.3
T1 – Inter-
observer
0.91 0.5 ± 20.2T1 may already be accurate enough to differentiate
cardiac amyloid patients from normals [21].
Post-contrast T1 in the present study was even more
variable between subjects than pre-contrast T1, attribut-
able to the many factors with influence on the contrast
kinetics (e.g. patient weight, hematocrit, renal function).
Miller et al. recently demonstrated that even though iso-
lated post-contrast T1 measurement showed significant
within-subject correlation with histological collagen vol-
ume fraction, the between-subject correlations were not
significant. Hence, isolated post-contrast T1 measure-
ment seems to be insufficient for assessing extracellular
volume fraction [22].
Aging was found to be associated with decreasing pre-
contrast T1 values. This is an interesting aspect that may
reflect early age-dependent alterations of myocardial
texture. Dall’Armellina et al. and Ugander et al. showed
that pre-contrast T1 times were increased in acute myo-
cardial ischemia [20,23]. Dass et al. reported increase in
pre-contrast T1 in cardiomyopathies. Hence, the present
reduction of pre-contrast T1 with age may sound contra-
dictory [24]. In contrast, in a rat model, diffuse myocar-
dial fibrosis was associated with a non-significant trend
towards lower pre-contrast T1 values [25]. Therefore our
data are stimulating to further analyze the value of
pre-contrast T1 mapping in non-ischemic heart disease
in future.
Conclusion
In conclusion, myocardial T2 and T1 mapping at 3 T are
feasible with a good diagnostic image quality, although
susceptibility artifacts related to the magnetic field
strength of 3 T triggered exclusion of myocardial seg-
ments from analysis. This study provides reference
values for myocardial T2 and T1 relaxation times per
slice and per segment for the specific MR setting, which
were deduced from a large cohort of healthy volunteers.
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http://jcmr-online.com/content/15/1/53With this approach a relatively high inter-subject distri-
bution became apparent, which may constitute a rele-
vant challenge for the definition of cut-offs that
differentiate healthy from diseased myocardium in clin-
ical practice.Study limitations
i) As hematocrit was not measured in this study, its
effect on T2 and T1 relaxation times could not be
assessed. ii) Whereas observer variability to assess T2
and T1 relaxation times was low, the inter-scan variabil-
ity was not assessed and deserves further investigation.
iii) Regarding T1 estimation by the applied MOLLI tech-
nique, there are known limitations to inversion efficiency
[26] and to evaluation of magnitude based data. The
inversion efficiency is also dependent on T2. At the time
the study was designed, an improved inversion pulse
designed for myocardial T1 mapping tailored for myo-
cardial T2 was not available yet. The limitations of evalu-
ating T1 based on magnitude images are described in a
recent publication [27]. By the time the study was
designed, the proposed phase-sensitive recon was not
yet available on our system.Additional files
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